Immunology

Maximize Your Impact in Immunology Research

Did you know that the CDC estimated vaccines will prevent 322 million illnesses, 21 million hospitalizations, and 732,000 deaths for Americans born between 1994 and 2013 over the course of their lifetimes? Our Taylor & Francis authors are improving vaccine efficiency one immunology research article at a time.

Browse our portfolio of immunology journals covering key subject areas from immunotherapies to vaccine development to cellular and molecular immunology. Our journal feature cutting edge reviews and original articles on vaccines, the immune response, and the powerful impact of immunization against infectious diseases. They cover vaccine technologies and platforms, adjuvants, therapeutic vaccines and vaccination for the control of non-communicable diseases.

Trust us with finding the perfect journal home for your next article where your research will join other world leading studies in its field.

“The review process was expeditious and editor was quite responsive and clear with feedback – which the author team appreciated very much. Thanks to Dr. Ron Ellis.’”

Published Author, Human Vaccines & Immunotherapeutics 

Browse Our Top Immunology Journals

Human Vaccines & Immunotherapeutics is an international journal of vaccinology and immunotherapy that publishes all aspects of work in these fields.

Oncoimmunology publishes international translational and clinical research into tumor immunology including anticancer therapies and immunotherapies.

Infectious Diseases publishes international research on all aspects of human infections including pathogenesis, diagnosis, and treatment of infectious diseases.

A peer-reviewed OA journal publishing across all areas of medicine as part of the Elevate Series

Emerging Microbes & Infections publishes research related to emerging infectious diseases, including epidemic surveillance, drug discovery and vaccine development.   

A MEDLINE-indexed peer-reviewed journal providing expert commentary on the development, application, and clinical effectiveness of new vaccines. Topics include vaccine technology, vaccine adjuvants, prophylactic vaccines, and therapeutic vaccines. It offers accelerated publication.

Find the best home for your research with our Journal Suggester. Our Suggester uses AI to match the subjects covered in your article to content across 4 million articles on Taylor & Francis Online.

We’re here to support you every step of the way in your submission journey from researching your options to drafting your paper to promoting your work.

Read the Latest Immunology Research

Article	Journal
Characteristics and methodological standards across systematic reviews with Meta-analysis of efficacy and/or effectiveness of influenza vaccines: an overview of reviews	Infectious Diseases
Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils	Emerging Microbes & Infections
Success of nano-vaccines against COVID-19: a transformation in nanomedicine	Expert Review of Vaccines
Characteristics and methodological standards across systematic reviews with Meta-analysis of efficacy and/or effectiveness of influenza vaccines: an overview of reviews	Infectious Diseases
Correlates of malaria vaccine efficacy	Expert Review of Vaccines
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies	Expert Review of Vaccines
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies Impact of the Delta variant on vaccine efficacy and response strategies	Expert Review of Vaccines
Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial	Emerging Microbes & Infections

“This was the fastest acceptance-to-published article I have ever experienced. I still can’t believe it. And the quality of the final product was excellent.”

Published Author, OncoImmunology

Go Beyond with Open Access

Publishing open access increases the visibility and readership of your research, helping you make an impact beyond your field. We offer a wide range of publishing options where you can choose to publish fully open access (OA) or hybrid. Many Taylor & Francis policies and services are available to support you in making choices that lead to more open scholarly communications.  

WHAT IS OPEN ACCESS?